Literature DB >> 16491118

Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.

O Aguilera1, M F Fraga, E Ballestar, M F Paz, M Herranz, J Espada, J M García, A Muñoz, M Esteller, J M González-Sancho.   

Abstract

Colorectal cancer is a major cause of cancer death worldwide. A number of key oncogenes and tumor suppressor genes have been proposed to drive progression from healthy colonic epithelia to malignant tumors, including members of the Wnt/beta-catenin pathway. Recently, CpG island promoter hypermethylation was shown to cause inactivation of two extracellular Wnt inhibitors in colon cancer: secreted frizzled-related proteins (sFRPs) and Wnt inhibitory factor-1 (WIF-1). Here, we show for the first time that another extracellular Wnt inhibitor, the DICKKOPF-1 (DKK-1) gene, is transcriptionally silenced by CpG island promoter hypermethylation in colon cancer cell lines (n=9), whereas treatment with the DNA-demethylating agent 5-aza-2-deoxycytidine restored DKK-1 expression. Restoration of DKK-1 function in non-expressing cells bearing a truncated APC (Adenomatous Polyposis Coli) gene had no effect on beta-catenin/T-cell factor-dependent transcription, but induced tumor suppressor-like features such as reduced colony formation density and tumor growth inhibition in nude mice. These results suggest additional functions for DKK-1 other than inhibiting canonical Wnt signaling. In primary colorectal tumors, DKK-1 was found hypermethylated in 17% (nine of 54) of cases. Furthermore, while for both SFRP-1 and WIF-1 methylation-associated silencing occurred across the whole spectrum of colorectal tumorigenesis, DKK-1 promoter was selectively hypermethylated in advanced colorectal neoplasms (Duke's C and D tumors).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491118     DOI: 10.1038/sj.onc.1209439

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  137 in total

Review 1.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.

Authors:  F Neri; D Dettori; D Incarnato; A Krepelova; S Rapelli; M Maldotti; C Parlato; P Paliogiannis; S Oliviero
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

Review 3.  Dickkopf1: a tumor suppressor or metastasis promoter?

Authors:  Mitchell E Menezes; Daniel J Devine; Lalita A Shevde; Rajeev S Samant
Journal:  Int J Cancer       Date:  2011-11-02       Impact factor: 7.396

Review 4.  The canonical Wnt signalling pathway and its APC partner in colon cancer development.

Authors:  Jean Schneikert; Jürgen Behrens
Journal:  Gut       Date:  2006-07-13       Impact factor: 23.059

Review 5.  Emerging therapeutic opportunities for skeletal restoration.

Authors:  Masanobu Kawai; Ulrike I Mödder; Sundeep Khosla; Clifford J Rosen
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

Review 6.  Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation.

Authors:  Wook-Jin Chae; Alfred L M Bothwell
Journal:  Differentiation       Date:  2019-06-12       Impact factor: 3.880

Review 7.  A Wnt survival guide: from flies to human disease.

Authors:  Andy J Chien; William H Conrad; Randall T Moon
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

8.  Restoration of ASC expression sensitizes colorectal cancer cells to genotoxic stress-induced caspase-independent cell death.

Authors:  Sujeong Hong; Inhwa Hwang; Yun-Sun Lee; Sangjun Park; Won-Keun Lee; Teresa Fernandes-Alnemri; Emad S Alnemri; You-Sun Kim; Je-Wook Yu
Journal:  Cancer Lett       Date:  2013-01-12       Impact factor: 8.679

Review 9.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

10.  Dkk-1 inhibits intestinal epithelial cell migration by attenuating directional polarization of leading edge cells.

Authors:  Stefan Koch; Christopher T Capaldo; Stanislav Samarin; Porfirio Nava; Irmgard Neumaier; Arne Skerra; David B Sacks; Charles A Parkos; Asma Nusrat
Journal:  Mol Biol Cell       Date:  2009-09-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.